Atreca, Inc. Depreciation/Fixed assets

Depreciation/Fixed assets of BCEL for past 10 years: annual, quarterly and twelve month trailing (TTM) including Depreciation/Fixed assets growth rates and interactive chart.


Highlights and Quick Summary

  • Annual Depreciation/Fixed assets for 2021 was 0.11 (a -11.76% decrease from previous year)
  • Annual Depreciation/Fixed assets for 2020 was 0.12 (a -59.23% decrease from previous year)
  • Annual Depreciation/Fixed assets for 2019 was 0.29 (a -13.53% decrease from previous year)
  • Twelve month Depreciation/Fixed assets ending September 30, 2022 was 0.17 (a 24.91% increase compared to previous quarter)
  • Twelve month trailing Depreciation/Fixed assets increased by 58.32% year-over-year
Trailing Depreciation/Fixed assets for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
0.17 0.13 0.13 0.11
Visit stockrow.com/BCEL for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Depreciation/Fixed assets of Atreca, Inc.

Most recent Depreciation/Fixed assetsof BCEL including historical data for past 10 years.

Interactive Chart of Depreciation/Fixed assets of Atreca, Inc.

Atreca, Inc. Depreciation/Fixed assets for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 0.11
2020 0.12
2019 0.29
2018 0.34
2017 0.32

Business Profile of Atreca, Inc.

Sector: Healthcare
Industry: Biotechnology